期刊文献+

钙拮抗剂干预对高血压合并左心室肥厚的影响 被引量:12

Effect of chacium channel blocker on left ventricular hypertrophy in essential hypertensives
暂未订购
导出
摘要 目的 探讨钙拮抗剂非洛地平逆转高血压 (EH )合并左心室肥厚 (L VH )的作用及其机制。方法 选择 EH合并 L VH的患者 30例 ,测定非洛地平治疗 (5~ 10 mg/ d) 2 4周前后左室重量指数 (L VMI)、胰岛素敏感指数 (ISI)及血浆肾素活性 (PRA)、血管紧张素 (Ang )、醛固酮 (AL D)、内皮素 (ET)、一氧化氮 (NO)、去甲肾上腺素 (NE)水平。结果 非洛地平治疗后 ,L VMI减小 (P<0 .0 1) ,ET降低 (P<0 .0 5 ) ,NO、ISI升高 (P均 <0 .0 1) ,而 PRA、Ang 、AL D、及 NE无显著变化。结论 钙拮抗剂非洛地平可以逆转 EH合并 L VH,其机制可能与非洛地平改善内皮细胞功能和胰岛素抵抗 ,而对肾素 -血管紧张素 -醛固酮系统 (RAAS)及交感神经系统 (SYS) Objective To investigate the mechanism of the reversal effect of felodipine on left ventricular hypertrophy(LVH)in patients with essential hypertension(EH).Methods Left ventricular mass index(LVMI),the levels of plasma renin activity(PRA),angiotensin Ⅱ(AngⅡ),aldosterone(ALD),endothelin(ET),nitric oxide(NO),norepinephrne(NE)and insulin sensitive index(SIS)were determined in 30 EH patients with LVH before and after administered felodipine(5~10mg/d,orally)for 24 weeks.Results After treatment,LVMI and the levels of ET were reduced obviously(P<0.01,P<0.05).ISI and the levels of NO were increased significantly(P<0.01).But the level of PRA,Ang Ⅱ,ALD and NE had no change.Conclusion Felodipine can reverse LVH and EH,it might be mediated by improving endothelial dysfunction and insulin resistance and not activating the rein-angiotensin-aldosterone system and the sympathetic nervous system.
出处 《山东医药》 CAS 北大核心 2004年第1期20-21,共2页 Shandong Medical Journal
关键词 钙拮抗剂 高血压 合并症 左心室肥厚 药物治疗 Chacium channel blocker Essential hypertension Left ventricular hypertrophy Vasoactive substances
  • 相关文献

参考文献9

  • 1李光伟,Step.,L.检测人群胰岛素敏感性的一项新指数[J].中华内科杂志,1993,32(10):656-660. 被引量:2126
  • 2刘晓光,黄佐.胰岛素抵抗与原发性高血压患者合并左心室肥厚的关系[J].中国循环杂志,1999,14(4):201-203. 被引量:8
  • 3梁黔生,郑智.左室肥厚的研究近况[J].心血管病学进展,2001,22(3):143-146. 被引量:37
  • 4徐瑞.高血压左室肥厚消退的治疗[J].心血管病学进展,2002,23(3):129-132. 被引量:18
  • 5Franz HM. Reinhard K. Left ventricular hypertrophy, a pressure independent cardiovascular risk factor, j cardiovasc pharmacol, 1993,22(suppl 1):713.
  • 6Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventrleular hypertrophy comparison to necropsy findings. Am J Cardiol, 1986,57:450-454.
  • 7Pahor M, Bernibei R, Sgidari A, et al. Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension, 1991, 18:148.
  • 8Hua L, Li C, Xia D, et al. Relationship between hypertensive left ventricular hypertrophy and levels of endothelin and nitric oxide. Hypertens Res, 2000,23 : 377-380.
  • 9Kamide K, Nagano M, Nakano N, et al. Insulin resistance and cardiovascular complications in patients with essential hypertension. Am J Hyperten,1996,9:1165-1171.

二级参考文献15

共引文献2180

同被引文献33

引证文献12

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部